Interactions between MAP kinase and oestrogen receptor in human breast cancer

European Journal of Cancer

Volumn 49, Issue 6, 2013, Pages 1176-1186

  McGlynn, Liane M ^a   Tovey, Sian ^a   Bartlett, John M S ^a,c   Doughty, Julie ^b   Cooke, Timothy G ^a   Edwards, Joanne ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Ligand dependent activation; Ligand independent activation; Oestrogen receptor; p44 42 MAPK; Subcellular localisation

Indexed keywords

ESTROGEN RECEPTOR; FELODIPINE; MITOGEN ACTIVATED PROTEIN KINASE; NEU DIFFERENTIATION FACTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CYTOPLASM; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ESTROGEN BINDING; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL NUCLEUS; CYTOPLASM; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MCF-7 CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEUREGULIN-1; PHOSPHORYLATION; SERINE; TIME FACTORS;

EID: 84875692374     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.11.020     Document Type: Article

References (26)

1. J.M. Hall, J.F. Couse, and K.S. Korach The multifaceted mechanisms of estradiol and estrogen receptor signaling J Biol Chem 276 40 2001 36869 36872
2. D. Chen, E. Washbrook, and N. Sarwar Phosphorylation of human estrogen receptor α at serine 118 by two distinct signal transduction pathways revealed by phosphorylation specific antisera Oncogene 21 2002 4921 4931
3. S. Ali, and R.C. Coombes Endocrine-responsive breast cancer and strategies for combating resistance Nat Rev Cancer 2 2 2002 101 112
4. S. Kato, H. Endoh, and Y. Masuhiro Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase Science 270 5241 1995 1491 1494
5. A.K. Shiau, D. Barstad, and P.M. Loria The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen Cell 95 7 1998 927 937
6. E.H. Kong, A.C.W. Pike, and R.E. Hubbard Structure and mechanism of the oestrogen receptor Biochem Soc Trans 31 2003 56 59
7. L.M. McGlynn, T. Kirkegaard, and J. Edwards Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients Clin Cancer Res 15 4 2009 1487 1495
8. G. Bunone, P.A. Briand, R.J. Miksicek, and D. Picard Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation EMBO J 15 9 1996 2174 2183
9. P.B. Joel, J. Smith, T.W. Sturgill, T.L. Fisher, J. Blenis, and D.A. Lannigan Pp 90(rsk1) regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167 Mol Cell Biol 18 4 1998 1978 1984
10. H. Kurokawa, and C.L. Arteaga ErbB (HER) receptors can abrogate antiestrogen action in human breast cancer by multiple signaling mechanisms Clin Cancer Res 9 1 Pt 2 2003 511S 515S
11. S. Tovey, B. Dunne, C.J. Witton, A. Forsyth, T.G. Cooke, and J.M.S. Bartlett Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer? Clin Cancer Res 11 13 2005 4835 4842
12. T. Kirkegaard, J. Edwards, and S. Tovey Observer variation in immunohistochemical analysis of protein expression, time for a change? Histopathology 48 7 2006 787 794
13. T. Takahashi, M. Ohmichi, and J. Kawagoe Growth factors change nuclear distribution of estrogen receptor-alpha via mitogen-activated protein kinase or phosphatidylinositol 3-kinase cascade in a human breast cancer cell line Endocrinology 146 9 2005 4082 4089
14. P.B. Joel, A.M. Traish, and D.A. Lannigan Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor Mol Endocrinol 9 8 1995 1041 1052
15. P.B. Joel, A.M. Traish, and D.A. Lannigan Estradiol-induced phosphorylation of serine 118áin the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase J Biol Chem 273 21 1998 13317 13323
16. S. Ito, K. Takeyama, and A. Yamamoto In vivo potentiation of human oestrogen receptor alpha by Cdk7-mediated phosphorylation Genes Cells 9 10 2004 983 992
17. Q. Lu, H. Ebling, J. Mittler, W.E. Baur, and R.H. Karas MAP kinase mediates growth factor-induced nuclear translocation of estrogen receptor alpha Febs Lett 516 1-3 2002 1 8
18. D. El Ashry, D.L. Miller, S. Kharbanda, M.E. Lippman, and F.G. Kern Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis Oncogene 15 4 1997 423 435
19. P. Maruvada, C.T. Baumann, G.L. Hager, and P.M. Yen Dynamic shuttling and intranuclear mobility of nuclear hormone receptors J Biol Chem 278 14 2003 12425 12432
20. W. Shao, E.K. Keeton, D.P. McDonnell, and M. Brown Coactivator AIB1 links estrogen receptor transcriptional activity and stability Proc Natl Acad Sci U S A 101 32 2004 11599 11604
21. Z. Yang, C.J. Barnes, and R. Kumar Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells Clin Cancer Res 10 11 2004 3621 3628
22. P. Fan, J. Wang, R.J. Santen, and W. Yue Long-term treatment with tamoxifen facilitates translocation of estrogen receptor + out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells Cancer Res 67 3 2007 1352 1360
23. R.B. Riggins, R.S. Schrecengost, M.S. Guerrero, and A.H. Bouton Pathways to tamoxifen resistance Cancer Lett 256 1 2007 1 24
24. R. de Leeuw, J. Neefjes, and R. Michalides A role for estrogen receptor phosphorylation in the resistance to tamoxifen Int J Breast Cancer 2011 2011 232435
25. N. Sarwar, J.S. Kim, and J. Jiang Phosphorylation of ER+ at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ER+ phosphorylation in breast cancer progression Endocr Relat Cancer 13 3 2006 851 861
26. V.S. Likhite, F. Stossi, K. Kim, B.S. Katzenellenbogen, and J.A. Katzenellenbogen Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity Mol Endocrinol 20 12 2006 3120 3132